Patients with thalassemia major should be screened for CD, especially cases with associated autoimmune diseases and growth failure even without typical symptoms of CD by measuring tTG IgA and for positive serologic patients performing an intestinal biopsy. This evidence concerns the gene CD79A and autoimmune disease.